Skip to Content
Merck
All Photos(1)

Documents

P-008

Supelco

Phenobarbital solution

1 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Synonym(s):

5-Ethyl-5-phenylbarbituric acid solution

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C12H12N2O3
CAS Number:
50-06-6
Molecular Weight:
232.24
MDL number:
MFCD00066494
UNSPSC Code:
41116107
PubChem Substance ID:
329820008
NACRES:
NA.24

grade

certified reference material

form

liquid

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

drug control

Narcotic Licence Schedule B (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)

concentration

1 mg/mL in methanol

technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

application(s)

forensics and toxicology

format

single component solution

storage temp.

-10 to -25°C

SMILES string

CCC1(C(=O)NC(=O)NC1=O)c2ccccc2

InChI

1S/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17)

InChI key

DDBREPKUVSBGFI-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Phenobarbital is the oldest and most widely used barbiturate. The drug is an anticonvulsant approved for treatment of all seizure types with the exception of absence seizures. This certified solution standard is suitable as starting material for the preparation of calibrators and controls in phenobarbital testing by GC/MS or LC-MS/MS.

Application


  • Fabrication of a Surface Molecularly Imprinted Polymer Membrane: Phenobarbital is utilized in the development of molecularly imprinted polymer membranes for the selective separation and extraction of various pharmaceutical compounds, enhancing the precision and efficiency of drug monitoring in clinical settings. This application leverages the specific binding properties of Phenobarbital to improve sample preparation techniques for complex biological matrices (Zhao et al., 2024).

  • An Isotope Dilution-Liquid Chromatography-Tandem Mass Spectrometry-Based Reference Measurement Procedure: Phenobarbital′s role in establishing reference measurement procedures underscores its importance in ensuring the accuracy and reliability of drug quantification in clinical laboratories. This application supports the standardization of laboratory measurements, critical for patient care and therapeutic monitoring (Schierscher et al., 2024).

Recommended products

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

related product

Product No.
Description
Pricing

B-041

Barbiturate Mix-5 solution, 250 μg/mL each component in methanol, ampule of 1.0 mL, certified reference material, Cerilliant®

P-004

Phenobarbital-D5 (side chain) solution, (deuterium label on side chain), 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

P-017

Phenobarbital-D5 (side chain) solution, (deuterium label on side chain), 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

P-018

Phenobarbital-D5 (ring) solution, (deuterium label on ring), 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

P-019

Phenobarbital-D5 (ring) solution, (deuterium label on ring), 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

P-075

Primidone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

B-070

Barbital solution, 1.0 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

A-150

Aprobarbital solution, 1 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

P-138

Primidone-D5 solution, 100 μg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

Signal Word

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Target Organs

Eyes,Central nervous system

Storage Class Code

3 - Flammable liquids

WGK

WGK 2

Flash Point(F)

49.5 °F - closed cup

Flash Point(C)

9.7 °C - closed cup

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

L Corcos et al.
Pharmacology & toxicology, 89(3), 113-122 (2001-10-09)
Phenobarbital has long been used as a sedative and antiepileptic drug. The drug is the representative of a myriad of lipophilic molecules able to evoke a pleiotropic response in the liver and also in prokaryotes and flies. A great deal
Susumu Kodama et al.
Drug metabolism reviews, 38(1-2), 75-87 (2006-05-11)
In the early 1960s, phenobarbital (PB) was shown to induce hepatic drug metabolism and the induction was implicated in the molecular mechanism of drug tolerance development. Since then, it has become evident that PB not only induces drug metabolism, but
Martin J Brodie et al.
Epilepsia, 53 Suppl 8, 40-46 (2012-12-12)
This article reviews the current position of phenobarbital using articles published since 2000 and speculates on its likely future contribution to epilepsy care. Over the last decade there have been no major double-blind randomized placebo-controlled or comparative trials with phenobarbital.
Shuzhen Liu et al.
Breast cancer research and treatment, 149(2), 439-448 (2015-01-02)
PAM50-defined breast cancer intrinsic subtypes and risk-of-relapse (ROR) scores are prognostic and predictive of endocrine therapy and some chemotherapy. We investigated the prognostic and predictive effect of PAM50 classifications by chemotherapy type. NCIC CTG MA.21 randomized 2,104 patients to doxorubicin
Caroline A Crowther et al.
The Cochrane database of systematic reviews, (1)(1), CD000164-CD000164 (2010-01-22)
Preterm infants are at risk of periventricular haemorrhage. Phenobarbital might prevent ischaemic injury or reduce fluctuations in blood pressure and blood flow in the brain. To assess the benefits and harms of giving phenobarbital to women at risk of imminent
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service